Skip to main content
Focused investors/ValueAct Capital

ValueAct Capital

As of Q2 2026, ValueAct Capital reported 18 long-equity positions worth $5.63B in aggregate.

Copy-investor backtest

Latest quarter
+11.81%
1-year
-6.13%
3-year
+68.78%
5-year
+54.42%
3-year vs S&P 500
-4.46%
5-year vs S&P 500
-19.26%
5-year top 5
+37.05%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when ValueAct Capital files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 3 of 17 rows. Rows without a quote are marked unavailable.

1VRXVALEANT PHARMACEUTICALS INTL COM25.84%Reduce -14.8%15,138,358$791.59MNo quoteNo quote
2SLESARA LEE CORP COM16.08%-34,918,822$492.36MNo quoteNo quote
3ITGARTNER GROUP INC NEW-CL A COM15.78%-20,790,013$483.37M$23.25No quote
4VRSNVERISIGN INC COM9.89%Add +57.4%11,411,869$302.99M$26.55No quote
5WSHWILLIS GROUP HOLDINGS LTD SHS7.57%Add +28.8%7,717,510$231.91MNo quoteNo quote
6BCRC R BARD INC COM7.45%Add +9.0%2,942,644$228.14MNo quoteNo quote
7SNASNAP ON TOOLS CORP COM4.88%Add +108.9%3,653,638$149.47M$40.91No quote
8BLUDIMMUCOR INC COM4.69%Add +54.4%7,540,665$143.65MNo quoteNo quote
9IMAINVERNESS MEDICAL INNOVATIONS COM4.55%Add +53.1%5,228,282$139.39MNo quoteNo quote
10NTYNBTY INC COM1.63%New1,464,700$49.81MNo quoteNo quote
11KARKAR AUCTION SERVICES INC COM0.91%-2,258,828$27.94MNo quoteNo quote
12ESENERGY SOLUTIONS INC COM0.41%Add +145.9%2,495,218$12.7MNo quoteNo quote
13IMAPRBINVERNESS MEDICAL INNOVATIONS PFDCONVSERB0.31%Add +1.1%48,264$9.52MNo quoteNo quote
17WCRXWARNER CHILCOTT PLC SHS A-Sold0$0No quoteNo quote
16MYGNMYRIAD GENETICS INC COM-Sold0$0No quoteNo quote
15MDZMDS INC COM-Sold0$0No quoteNo quote
14BFHALLIANCE DATA SYSTEM CORP COM-Sold0$0No quoteNo quote